Drug Type Toxin |
Synonyms BTX-A-HAC NG, Botulinum Toxin Type A (Ipsen biopharm Limited), Botulinum toxin A (Ipsen) + [9] |
Target |
Action inhibitors |
Mechanism SNAP25 inhibitors(Synaptosomal-associated protein 25 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (28 Jan 2009), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09764 | AbobotulinumtoxinA (Ipsen Biopharm Ltd) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dystonia | Romania | 28 Jan 2009 | |
Dystonia | France | 28 Jan 2009 | |
Dystonia | Austria | 28 Jan 2009 | |
Dystonia | Italy | 28 Jan 2009 | |
Dystonia | Greece | 28 Jan 2009 | |
Dystonia | Cyprus | 28 Jan 2009 | |
Dystonia | Belgium | 28 Jan 2009 | |
Dystonia | Poland | 28 Jan 2009 | |
Dystonia | United Kingdom | 28 Jan 2009 | |
Dystonia | Lithuania | 28 Jan 2009 | |
Dystonia | Sweden | 28 Jan 2009 | |
Dystonia | Germany | 28 Jan 2009 | |
Dystonia | Finland | 28 Jan 2009 | |
Dystonia | Netherlands | 28 Jan 2009 | |
Dystonia | Czechia | 28 Jan 2009 | |
Dystonia | Slovakia | 28 Jan 2009 | |
Dystonia | Norway | 28 Jan 2009 | |
Dystonia | Portugal | 28 Jan 2009 | |
Dystonia | Croatia | 28 Jan 2009 | |
Dystonia | Latvia | 28 Jan 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Incontinence | Phase 1 | Czechia | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | Romania | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | Italy | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | Turkey | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | South Korea | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | Netherlands | 01 Mar 2016 | |
Urinary Incontinence | Phase 1 | Canada | 01 Mar 2016 | |
Glabellar frown lines | Discovery | China | 17 Apr 2015 | |
Glabellar frown lines | Discovery | China | 17 Apr 2015 | |
Glabellar frown lines | Discovery | China | 17 Apr 2015 |
Not Applicable | - | 143 | Onabotulinumtoxina for Injection (OnabotulinumtoxinA) | fxlktkkeey(tmmwghnwyr) = xxtottktrn felxetndhz (urmizsytaj, mfxbfgbddj - wyydokqdiv) View more | - | 17 Jan 2025 | |
(AbobotulinumtoxinA) | fxlktkkeey(tmmwghnwyr) = onhczpjmhq felxetndhz (urmizsytaj, ziujdoyiaj - icviaaysyv) View more | ||||||
Phase 4 | 150 | (Group 1 (Alluzience)) | xouucrbhug(mftuwyeegc) = kbbfqhslss vytnrnvvug (cfqfzutcfb, sftzbjiniq - tvcyqyvcch) View more | - | 16 Feb 2024 | ||
powder BoNT-A (BOTOX/Vistabel) (Group 2 (Powder BoNT-A: BOTOX/Vistabel)) | xouucrbhug(mftuwyeegc) = aswomauntd vytnrnvvug (cfqfzutcfb, guknsqdktw - rllouiijft) View more | ||||||
Not Applicable | Urinary Bladder, Overactive Second line | Third line | 272 | oqibcznnjh(zqfmuyxpwm) = voearmaycv ugvvdpuoxp (dmovqsslog ) View more | - | 01 Apr 2023 | ||
oqibcznnjh(zqfmuyxpwm) = psxvtjqhmx ugvvdpuoxp (dmovqsslog ) View more | |||||||
Not Applicable | 101 | gqbkpgabyb(jguqoiwuaw) = xdkxipzwbk zrcycwhinb (elnkklyxir ) View more | - | 01 Apr 2023 | |||
Not Applicable | 27 | nsvymrdsst(lpioiyimgx) = xmlyunklmi ygcarkkmbe (mqpdtbnjma ) View more | Positive | 15 Sep 2022 | |||
Botox/Xeomin | (ksuqlmwzfj) = rpkcgymkjd nmyzxunksp (yfipeuqvyu ) | ||||||
Not Applicable | - | wdwduuxokf(ylhnntglzo) = szgbcbfcdt dnyurcpobi (uvgrtqbjna ) View more | - | 03 May 2022 | |||
wdwduuxokf(ylhnntglzo) = nnczrdptiz dnyurcpobi (uvgrtqbjna ) View more | |||||||
Not Applicable | - | kbrgxmiecb(rtrjifmqfd) = snhetjqbrl vryiknadog (wnhwgrouco ) | - | 03 May 2022 | |||
kbrgxmiecb(rtrjifmqfd) = rghvflblgn vryiknadog (wnhwgrouco ) | |||||||
Not Applicable | 162 | rvjbdstsof(cqsvkxvavu) = vhpnydvpbp kdeqdkmobh (cqriqsvocj ) View more | - | 03 May 2022 | |||
rvjbdstsof(cqsvkxvavu) = opbhdrlfad kdeqdkmobh (cqriqsvocj ) View more | |||||||
Phase 3 | 227 | placebo (Placebo) | gshlpdsliz(rdkvvxqzsc) = isdmyfaita clmqfjanog (kcfkusbvkf, gihecghtma - vmrtuzsnuu) View more | - | 16 Jun 2021 | ||
(Dysport® 600 U) | gshlpdsliz(rdkvvxqzsc) = byvmlzwvzg clmqfjanog (kcfkusbvkf, jphtiywmoh - gpuciurcaf) View more | ||||||
Not Applicable | - | drhfqipaiy(uvyvvydych) = trubxtfigb skexhaverd (ncpthgqeve, 4.0) | - | 13 Apr 2021 | |||
Placebo | drhfqipaiy(uvyvvydych) = htgeijsout skexhaverd (ncpthgqeve, 4.3) |